Adar Poonawalla: News
22 Dec 2022
Serum Institute of IndiaSerum Institute seeks DCGI's approval for Covovax as booster dose
The Serum Institute of India (SII) has sought the Drugs Controller General of India's (DCGI) approval to roll out its Covovax in the market as a booster dose for adults.
26 Nov 2022
Serum Institute of IndiaCovishield manufacturer SII duped of Rs. 1 crore, 7 arrested
In a major cheating and cyber fraud case, the Serum Institute of India (SII) has been duped of Rs. 1 crore.
26 Jul 2022
VaccineIs SII developing vaccine for monkeypox? Here's what Poonawalla said
Amid the rising monkeypox scare, Serum Institute of India (SII) CEO Adar Poonawalla said on Tuesday they are in talks with American biotech company Novavax to develop a messenger RNA (mRNA) vaccine for it.
19 Jan 2022
World Health OrganizationOnly faster COVID-19 vaccinations can end pandemic: Adar Poonawalla
Billions need to be vaccinated at a faster rate to reach the end of the COVID-19 pandemic, said Adar Poonawalla, CEO of the Serum Institute of India (SII), which manufactures the COVID-19 vaccine Covishield.
15 Dec 2021
Serum Institute of IndiaSII to launch COVID-19 vaccine for children in 6 months
The Serum Institute of India is looking to launch a COVID-19 vaccine for children in six months, SII CEO Adar Poonawalla said Tuesday.
17 Jul 2021
EuropeEU body says it didn't receive application for Covishield approval
The European Medicines Agency (EMA) said it has not received any application for the authorization of the coronavirus vaccine Covishield.
26 Jun 2021
COVID-19Serum to begin Covovax trials on children in July
The Serum Institute of India (SII) will soon apply for regulatory approval to conduct clinical trials of Covovax on children in India.
17 Jun 2021
VaccineCovovax India launch by September; trial for kids soon: SII
The Serum Institute of India (SII) is looking to launch the COVID-19 vaccine developed by the United States firm Novavax in India by September.
03 May 2021
VaccineReports claiming fresh COVID-19 vaccine orders not placed baseless: Government
The Union Health Ministry on Monday refuted media reports that claimed that the central government had not placed fresh orders for COVID-19 vaccines.
02 May 2021
VaccineGetting aggressive calls from powerful people: SII CEO Adar Poonawalla
Serum Institute of India CEO Adar Poonawalla has revealed that his decision to fly to London when India is facing a COVID-19 second wave was largely due to the threats he had been facing.
28 Apr 2021
VaccineCovishield price reduced to Rs. 300 for states: Adar Poonawalla
Adar Poonawalla, the CEO of the Serum Institute of India (SII), on Wednesday announced that the price of the COVID-19 vaccine Covishield was being reduced from Rs. 400 to Rs. 300 for states.
15 Apr 2021
VaccineCOVID-19 vaccine production hit as US, Europe obstruct raw material
As India faces a record surge in coronavirus infections, Serum Institute of India (SII) CEO Adar Poonawalla has raised concerns about the United States and Europe holding back key vaccine raw material.
08 Apr 2021
Serum Institute of IndiaAstraZeneca serves legal notice to Serum Institute over vaccine delays
Serum Institute of India (SII), the manufacturer of the coronavirus vaccine Covishield, has been served a legal notice by the drug maker AstraZeneca over delays in vaccine supply, the company's CEO Adar Poonawalla confirmed in an interview earlier this week.
06 Apr 2021
VaccineCovishield 90% effective if doses given 2-3 months apart: Poonawalla
The efficacy of the COVID-19 vaccine Covishield could increase to 90% if the two doses are given 2.5-3 months apart, Serum Institute of India CEO Adar Poonawalla said Monday.
27 Mar 2021
Serum Institute of IndiaSerum CEO Poonawalla hopes to launch second vaccine by September
Serum Institute of India CEO Adar Poonawalla today said that his company hopes to launch its second coronavirus vaccine by September this year.
05 Mar 2021
World Health OrganizationAdar Poonawalla, WHO scientist warn of delays in vaccine production
Adar Poonawalla, the head of the world's biggest vaccine maker, and the World Health Organization's (WHO) chief scientist have said that the manufacturers of coronavirus vaccine doses are facing a global shortage of the raw materials required to produce the doses.
22 Jan 2021
PuneAfter SII fire, BCG, rotavirus vaccine production to be hit
Thursday's fire at Pune's Serum Institute of India will impact the production of BCG and rotavirus vaccines in the future, the company said on Friday.
21 Jan 2021
PunePune: Fire breaks out at Serum Institute of India
On Thursday afternoon, a fire broke out at the Terminal 1 gate of Serum Institute of India, Pune.
11 Jan 2021
Narendra ModiRs. 200 per vaccine dose: SII receives government's purchase order
The Pune-based Serum Institute of India (SII) has received the purchase order for COVID-19 vaccines from the central government, officials said on Monday.
05 Jan 2021
Serum Institute of IndiaSII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.
04 Jan 2021
CoronavirusPrivate hospitals may get coronavirus vaccine by March: Serum CEO
While the Indian government has prioritized healthcare workers and high-risk individuals in its vaccine program, doses of the coronavirus vaccine will be available for private companies, hospitals, and individuals by as early as March, the CEO of Serum Institute of India (SII), Adar Poonawalla, said on Sunday.
03 Jan 2021
India'Finally paid off,' says Adar Poonawalla after Covishield gets approval
Serum Institute of India's (SII) chief Adar Poonawalla today wished everyone a happy new year along with a great announcement.
28 Nov 2020
Narendra ModiApplying for Covishield's emergency approval in 2 weeks: SII
The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.
23 Nov 2020
IndiaCan launch 100 million vaccine doses by January-February, says Poonawalla
The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.
20 Nov 2020
Oxford UniversityOxford vaccine to be available by April 2021 in India
Pune-based Serum Institute of India, which has partnered with Oxford University and British pharma giant AstraZeneca, plans to seek an emergency approval from the government of India next month, for providing the coronavirus vaccine to "corona warriors" and the elderly.
14 Nov 2020
IndiaIndia to get 10cr COVID-19 vaccine doses by December: SII
The Serum Institute of India is hoping to produce 100 million (10 crore) doses of AstraZeneca and Oxford University's COVID-19 vaccine, CEO Adar Poonawalla said.
08 Nov 2020
Serum Institute of IndiaVaccine tracker: Covishield trials running smoothly; COVAXIN expected by February
Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.
05 Nov 2020
IndiaAffordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla
Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.
01 Nov 2020
CoronavirusVaccine tracker: Covishield expected by December; Moderna readies for launch
It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.
27 Sep 2020
IndiaPM's vaccine arrangements will take care of all: Adar Poonawalla
As India's COVID-19 vaccine strategy becomes a point of debate, Adar Poonawalla has expressed confidence over Prime Minister Narendra Modi's vision to protect Indian citizens from the ongoing pandemic.
16 Sep 2020
OxfordAfter setback, Serum allowed to resume Oxford's coronavirus vaccine trial
Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process.
14 Sep 2020
Independence DayCoronavirus vaccine won't be available for all before 2024-end: Poonawalla
Adar Poonawalla, the CEO of the Serum Institute of India (SII), that has taken up the mammoth task of mass-producing the vaccine for novel coronavirus, asserted that the vaccine will not be available for the entire world before the end of 2024.
19 Aug 2020
VaccineIndia: Serum Institute's COVID-19 vaccine goes into Phase-2/3 trials
In a major development, Adar Poonawalla's Serum Institute of India has started the Phase-2/3 trial of a promising COVID-19 vaccine licensed from AstraZeneca and Oxford University.
11 Aug 2020
OxfordIndia likely to have COVID-19 vaccine by December: Adar Poonawalla
India should have a vaccine to exit the COVID-19 pandemic by the end of this year.
28 Jul 2020
IndiaOxford's COVID-19 vaccine: India readies five sites for human trials
India has prepared five sites for the final human trials phase of the potential COVID-19 vaccine developed by Oxford University, reports PTI.
24 Jul 2020
Oxford UniversityMeet Adar Poonawalla, the man bringing COVID-19 vaccines to India
In the fight against COVID-19, or should we say the worst health crisis of our time, several institutes/organizations are racing to develop vaccines, anti-viral treatments.
22 Jul 2020
OxfordCoronavirus vaccine will be available by 2021? Adar Poonawalla hopeful
Adar Poonawalla, the chief of Serum Institute of India (SII), is hoping that vaccine to fight coronavirus will be available in India by the first quarter of 2021.
26 Apr 2020
OxfordIndia will start COVID-19 vaccine production next month: Details here
In a major development, Cyrus S. Poonawalla's Serum Institute of India has confirmed that it will start making a vaccine for COVID-19 next month.